BioUtah News
-
Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s…
-
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
Recent pathogens illustrate need for improved situational awareness capabilities, such as those provided by the Co-Dx PCR point-of-care…
-
BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
Funds will fuel sales team expansion and broader market access, advancing the company’s leadership in Implantable Tibial Neuromodulation…
-
PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
351-patient trial completion marks a key milestone for the Celeste® program; topline data to be presented May 26…
-
AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA]…
-
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society’s 2026 Annual Meeting
VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of…
-
Two ARUP Medical Directors Receive Career Achievement Awards
Two ARUP Medical Directors Receive Career Achievement Awards
-
Canary Speech Introduces Free Voice-Based Check-In for Consumers to Help Identify Early Signs of Mental Health Decline
As gaps in early detection persist, a 45-second voice analysis offers a new way to identify signals of…
-
What to Know About the Reauthorized SBIR/STTR Grant Programs
What to Know About the Reauthorized SBIR/STTR Grant Programs
-
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
-
Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
-
Freyya Wins San Antonio TechFuel 2026 Competition
Freyya Wins San Antonio TechFuel 2026 Competition
-
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
-
PhotoPharmics Phase 2 Parkinson’s Disease
PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.
-
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
-
Freyya Selected as Finalist for Tech Fuel 2026
Freyya Selected as Finalist for Tech Fuel 2026
-
The “White Glove” Delivery: How a Joke Landed Me in Iceland
The “White Glove” Delivery: How a Joke Landed Me in Iceland
-
Owlet Dream Duo™ 3 Named ‘Best for Monitoring Baby’s Health’ in PARENTS 2026 Best for Baby Awards
The Only Pediatric Health Platform Pairing an FDA-Cleared Infant Wearable with a Cybersecurity-Certified Video Monitor Earns Top Recognition…
-
Kimbell & Associates: Highlights of President Trump’s FY 2027 Budget Request
Kimbell & Associates offers highlights of President Trump’s FY 2027 Budget Request
-
Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share
By Henry O’Connell, Canary Speech Five years into caring for a patient, a primary care physician saw her…
-
University of Utah Earns Dual Recognition in Global and U.S. Patent Rankings
Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The…
-
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader…
-
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target…
-
TWO YEAR DATA ON EDWARDS LIFESCIENCES’ EVOQUE SYSTEM CONTINUE TO DEMONSTRATE SIGNIFICANT AND SUSTAINED PATIENT BENEFITS
TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient…
-
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
Via OrthoSpineNews Major clinical milestone marks SINTX’s entry into the foot and ankle reconstruction market and advances…
-
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia’s Sudair Industrial City
Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic…
-
Nelson Labs® Offers Rare Inside Look at Lab Expansion Designed to Help Protect Patient Safety
Salt Lake City–based laboratory opens normally restricted space to invited guests, highlighting the behind‑the‑scenes work that helps keep…
-
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient.
-
BioUtah Presents at Medical Korea 2026
BioUtah president & CEO, Kelvyn Cullimoire, was invited by the Korean Health Industry Development Institute (KHIDI), an agency…
-
BioUtah CEO, Kelvyn Cullimore, Makes the Rounds in DC
BioUtah CEO, Kelvyn Cullimore, Makes the Rounds in DC
-
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)
First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease.
-
BIOUTAH JOINED NATIONAL CONVENING ON AMERICA’S BIOTECH MOMENT
Biotech is playing an increasingly important role in U.S. economic competitiveness and national security, and Utah plays a…
-
Kolosis BIO® Expands Surgical Biologics Portfolio with Launch of APEXecm™
The addition of APEXecm reflects Kolosis’s continued commitment to developing and commercializing best-in-class solutions for the surgical community
-
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic…
-
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for…
-
Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease
For Fabry patients, a potential path to converting 130 clinic visits into one treatment every five years.
-
BioMarin Presents New Data on Positive Impact of Early Treatment With VOXZOGO® on Proportionality, Arm Span in Children with Achondroplasia at 2026 ACMG Meeting
New results demonstrate early VOXZOGO treatment leads to durable and sustained improvements in skeletal growth-related health outcomes, including…
-
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
-
Springboard Enterprises Announces 2026 Women’s Health Accelerator Cohort
Women-led companies join Springboard’s accelerator to advance innovation across the women’s health landscape.
-
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
